KZIA vs AAPL: Which Stock is Better?
Side-by-side comparison of Kazia Therapeutics Ltd and Apple Inc in 2026
KZIA
Kazia Therapeutics Ltd
$11.22
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | KZIA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $124.78M | N/A | KZIA |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | 3.1% | 0.2% | KZIA |
| Gross Margin | 100.0% | 47.3% | KZIA |
Analyze KZIA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KZIA or AAPL a better investment?
Comparing KZIA and AAPL: Kazia Therapeutics Ltd has a market cap of $124.78M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KZIA and AAPL?
KZIA (Kazia Therapeutics Ltd) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KZIA or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KZIA or AAPL?
KZIA has higher revenue growth at 3.1% vs 0.2% for AAPL.
Which company is more profitable: KZIA or AAPL?
Kazia Therapeutics Ltd (KZIA) has higher gross margins at 100.0% compared to 47.3% for AAPL.
Which is the larger company: KZIA or AAPL?
Kazia Therapeutics Ltd (KZIA) is larger with a market cap of $124.78M compared to N/A for AAPL.
Should I buy KZIA or AAPL in 2026?
Both KZIA and AAPL have investment merit. KZIA trades at $11.22 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KZIA and AAPL stock?
Key differences: Market Cap ($124.78M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (3.1% vs 0.2%), Gross Margin (100.0% vs 47.3%).